New registry tracks rotarex device for leg artery blockages
NCT ID NCT07016698
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This study is a registry that will follow 600 people with peripheral artery disease (PAD) who are treated with the Rotarex device, which rotates to remove blockages in leg arteries. The goal is to see how well the device works in everyday medical practice and to track any major complications within 30 days. Participants must have blockages in the leg arteries below the groin and be at least 22 years old.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE(PAD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Radiology and Imaging Specialists
RECRUITINGLakeland, Florida, 33805, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vital Heart and Vein
RECRUITINGHumble, Texas, 77338, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.